GILD

Gilead Sciences Inc

Jun 04 • 04:00PM ET

129.18

+0.19 0.15 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: AMGN REGN VRTX BIIB ABBV BMY LLY MRK ALNY ARGX

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	17.58	EPS (ttm)	7.35	Insider Own	0.14%	Shs Outstand	1.24B	Perf Week	-5.17%
Market Cap	160.39B	Forward P/E	13.39	EPS next Y	9.65	Insider Trans	-18.22%	Shs Float	1.24B	Perf Month	-3.22%
Enterprise Value	172.66B	PEG	1.46	EPS next Q	-6.59	Inst Own	88.80%	Short Float	1.87%	Perf Quarter	-11.00%
Income	9.22B	P/S	5.38	EPS this Y	-100.73%	Inst Trans	-1.42%	Short Ratio	3.77	Perf Half Y	4.25%
Sales	29.79B	P/B	6.82	EPS next Y	16229.26%	ROA	16.35%	Short Interest	23.14M	Perf YTD	5.25%
Book/sh	18.93	P/C	16.34	EPS next 5Y	9.15%	ROE	43.19%	52W High	157.29 -17.87%	Perf Year	18.49%
Cash/sh	7.91	P/FCF	15.68	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	104.46 23.66%	Perf 3Y	65.85%
Dividend Est.	3.24 (2.51%)	EV/EBITDA	11.69	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	2.48% 2.50%	Perf 5Y	91.58%
Dividend TTM	3.19 (2.47%)	EV/Sales	5.80	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.27	Perf 10Y	49.95%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	42.14	Recom	1.52
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-2.11%	Beta	0.34	Target Price	160.72
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-3.86%	Rel Volume	1.97	Prev Close	128.99
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	0.25%	Avg Volume	6.13M	Price	129.18
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	12,087,410	Change	0.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)